BARINTHUS BIOTHERAPEUTICS PLC (BRNS) Reports the reporting period Financial Results
BARINTHUS BIOTHERAPEUTICS PLC (BRNS) announced its financial results for the period ending the reporting period.
Key Financial Highlights:
Revenue: 14969
Net Income: Not disclosed
EPS: Not disclosed
Cash and equivalents: 70456
expected in the second half of 2026
targeting metabolic and autoimmune diseases, with four clinical data milestones expected within 18 months of the closing of the transaction.•In December 2025
📋 BARINTHUS BIOTHERAPEUTICS PLC (BRNS) - Financial Results
Filing Date: 2026-03-13
Accepted: 2026-03-13 08:03:44
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
Structured Data: